The technology may be safe, but approving it without clearly identifying it as genetically altered undermines consumer trust
- Health Canada has approved gene-edited pork without labelling, so Canadians may buy it without knowing how it was produced.
- This approval was handled quietly, continuing a pattern where food decisions are made with little public explanation.
- The technology itself is not the concern, as gene editing is widely accepted by regulators and already used in agriculture.
- The real issue is transparency, because consumers expect clear information about how their food reaches store shelves.
- Without labelling, consumer choice is reduced and trust in the food system is weakened.
Health Canada has quietly approved the sale of gene-edited pork in Canada without labelling, once again acting as though Canadians do not need to know how the food they eat is produced.
This decision follows a familiar pattern in Canadian food regulation: scientific assessments are completed and approvals are granted quietly, with consumer communication treated as an afterthought.
Health Canada does not appear to have changed its approach following its recent experience with cloned animal products. Last fall, the agency approved meat derived from the offspring of cloned animals, again without a public announcement. When the information surfaced, consumer reaction was swift and negative, forcing Health Canada to pause that approval approach.
Under current rules, gene-edited pork, which involves making small, precise changes to an animal’s DNA to improve traits such as disease resistance or productivity without adding genes from other species, is treated much like regular pork. Because no foreign DNA is added, Health Canada applies the same rules used for conventionally bred animals, which is why no labelling is required. Regulators and scientists broadly agree that the technology is safe, well understood, and can help improve farm efficiency, resilience to climate stress and, over time, price stability.
But safety is not the issue.
The issue is consumer trust.
As with cloning, Canadians want to know what they are buying. Transparency is not an attack on innovation; it is a fundamental principle of consumer respect. Regulators and industry alike have long shielded consumers from information about production technologies, fearing disclosure would provoke backlash. This approach has often produced the opposite outcome, undermining confidence when information eventually emerges.
This inconsistency is difficult to justify. As of Jan. 1, Health Canada now mandates prominent front-of-package labels for fat, sugar and sodium content. If consumers are entitled to that information, it is hard to argue that identifying gene-edited meat at the point of purchase is excessive or dangerous. Information itself does not harm consumers; withholding it does.
There are also important market implications. Organic and niche producers who choose not to use gene-editing technologies lose the ability to clearly differentiate their products. Markets only work when consumers can make informed choices. Innovation thrives not only when technologies evolve, but when consumers are able to understand and compare those differences.
Blending gene-edited meat into the conventional supply without disclosure effectively forces the industry into a single production standard, one that prioritizes cost efficiency over consumer preference. The result is regulatory uniformity that suppresses choice while doing little to address the pressures driving meat prices higher. Health Canada’s approval allows gene-edited pork to be sold in Canada, even if widespread commercial availability is still emerging. Canadians are already paying more for meat; opacity will not improve affordability or confidence.
Gene editing is not new to agriculture. It has been used in crops for years, including rice, canola and tomatoes. But livestock is different. Food is shaped not only by scientific risk, but by perception, ethics and values. Regulators and industry must acknowledge that reality rather than dismiss it.
The conclusion is straightforward: gene-edited and cloned food products should be clearly labelled. Not because they are unsafe, but because transparency is essential for trust, market integrity and long-term acceptance.
Dr. Sylvain Charlebois is a Canadian professor and researcher in food distribution and policy. He is senior director of the Agri-Food Analytics Lab at Dalhousie University and co-host of The Food Professor Podcast. He is frequently cited in the media for his insights on food prices, agricultural trends, and the global food supply chain.
Explore more on Agriculture, Food safety, Food industry, GMO, Consumer information, Ethics
The views, opinions, and positions expressed by our columnists and contributors are solely their own and do not necessarily reflect those of our publication.
Troy Media empowers Canadian community news outlets by providing independent, insightful analysis and commentary. Our mission is to support local media in helping Canadians stay informed and engaged by delivering reliable content that strengthens community connections and deepens understanding across the country.
